Entresto (sacubitril/valsartan)

pCPA File Number: 21558
Negotiation Status:
Active Negotiation
Indication(s):
Heart failure, NYHA class II or III
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable